IMB Dx, Inc. (KOSDAQ:461030)
12,080
+230 (1.94%)
At close: Dec 5, 2025
IMB Dx Market Cap
IMB Dx has a market cap or net worth of 169.33 billion as of December 5, 2025. Its market cap has decreased by -14.45% in one year.
Market Cap
169.33B
Enterprise Value
146.49B
Revenue
4.26B
Ranking
n/a
PE Ratio
n/a
Stock Price
12,080.00
Market Cap Chart
Since April 3, 2024, IMB Dx's market cap has decreased from 503.73B to 169.33B, a decrease of -66.38%. That is a compound annual growth rate of -47.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 169.33B | 13.43% |
| Dec 30, 2024 | 149.29B | -70.36% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 77.77T |
| Celltrion | 40.11T |
| ALTEOGEN | 24.41T |
| ABL Bio | 10.51T |
| SK Biopharmaceuticals | 10.49T |
| Yuhan | 8,755.13B |
| LigaChem Biosciences | 7,139.05B |
| Peptron | 6,540.52B |